Find investors who align with your industry, stage, and vision. Unlock Chris Colecchi’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors todayChris Colecchi is a Venture Capital, Private Equity Firm, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as FineHeart, Provasculon, Laurantis Pharma, DecImmune Therapeutics, Gila Therapeutics, Herantis Pharma, Aria CV, Remedy Pharmaceuticals, Apama Medical, CroíValve, ZZ Biotech, Adient Medical, HAYA Therapeutics, Intravascular Imaging Incorporated, NIDO, G.I. Windows, NuPulseCV480 Biomedical, Cardero Therapeutics, Epirium Bio, Allosteros, AtaCor Medical, Alleviant Medical, CardiaLen, Aggamin Biologics, Mellitus, Basking Biosciences, InfoBionic, Vectorious Medical Technologies, Ischemia Care, Capricor Therapeutics, CellAegis Devices, Renovacor, Vascular Graft Solutions, CardiAQ Valve Technologies, Antag Therapeutics, Ventrinova, Pulmokine, Broadview Ventures, Inc., BioKier, Zumbro Discovery, Viridian Therapeutics, Acesion Pharma, Aeromics, . Over time, Chris Colecchi has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Chris Colecchi is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Wellness, Women Founded, HR Tech, Life Science, Diabetes, Manufacturing, Biotechnology, Tissue Regeneration, Consumer Health, Medical Devices, Electronic Health Records (EHR), Health and Hospital Services, Innovation, Clinical Trials, Research, Gene Therapy, Digital Health, Medical, Information Technology, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Chris Colecchi, as their portfolio suggests a familiarity and interest in this area.
Understanding Chris Colecchi’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today